Sign in

CIK 0001377121 · Large accelerated filer

Protagonist Therapeutics, Inc

Sign in to watch
Ticker
PTGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980505495
Phone
(510) 474-0170
Business address
7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
Former names
Protagonist Therapeutics Inc, Protagonist Inc
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 8-K Event Executive or director change
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G Stake Amended Statement of Ownership
  12. SC 13G Stake Amended Statement of Ownership
  13. 4 Open-market buy Director bought 8,000 shares at $5.70 ($45,620)
  14. 4 Open-market buy EVP Clinical Operations bought 30,000 shares at $5.13 ($153,900)
  15. 4 Open-market buy Chief Financial Officer bought 1,175 shares at an average $5.10 ($5,987)
  16. 4 Open-market buy President and CEO bought 30,000 shares at an average $5.62 ($168,500)
  17. 8-K Event Other events
  18. 8-K Event Material agreement
  19. 424B5 Offering Prospectus
  20. 4 Option exercise President and CEO acquired 4,000 shares (option exercise)

Page 23 of 36 · 707 filings